Successful Treatment of Intracranial Hemorrhage with Recombinant Activated Factor VII in a Patient with Newly Diagnosed Acute Myeloid Leukemia: A Case Report and Review of the Literature

Intracranial hemorrhage (ICH) is a common complication in acute myeloid leukemia (AML) patients with an incidence rate of 6.3% (1). Bleeding disorders related to disseminated intravascular coagulation (DIC) are common complications in AML cases (2). Recombinant activated Factor VII [rFVIIa (NovoSeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Pemmaraju, Naveen, Sasaki, Koji, Johnson, Daniel, Daver, Naval, Afshar-Kharghan, Vahid, Chen, Merry, Ahmed, Sairah, Colen, Rivka R., Kwon, Michael, Huh, Yang, Borthakur, Gautam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324079/
https://www.ncbi.nlm.nih.gov/pubmed/25717439
http://dx.doi.org/10.3389/fonc.2015.00029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324079/
https://www.ncbi.nlm.nih.gov/pubmed/25717439
http://dx.doi.org/10.3389/fonc.2015.00029

Ejemplares similares